Description

Rabimak (rabeprazole) Coated Tablets 10 mg. №14

Ingredients:

Each coated tablet contains 10 mg of rabeprazole sodium as the active ingredient.

Dosage:

The usual dose is one tablet daily before a meal. Follow your doctor’s instructions.

Indications:

Rabimak tablets are indicated for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and Helicobacter pylori eradication in combination with antibiotics.

Contraindications:

Do not use Rabimak if you are allergic to rabeprazole or similar medications. Consult your doctor if you have liver disease.

Directions:

Swallow the tablet whole with water. Do not crush or chew. It is best taken before a meal.

Scientific Evidence:

Rabeprazole, the active ingredient in Rabimak, belongs to the class of proton pump inhibitors (PPIs) known for their potent acid-suppressing effects. Studies have shown that rabeprazole is effective in treating GERD, peptic ulcers, and other acid-related disorders by inhibiting the proton pump in the gastric parietal cells, thus reducing acid secretion.

Additional Information:

Rabimak has been well-studied in various clinical trials, demonstrating its efficacy and safety profile. It is considered a first-line treatment for GERD and peptic ulcers due to its fast onset of action and long-lasting acid suppression. Patients taking Rabimak should be monitored for any signs of adverse effects, especially with prolonged use.

Comparative studies have shown that rabeprazole may have a faster onset of action and a longer duration of acid suppression compared to other PPIs, making it a preferred choice for many healthcare providers in the management of acid-related disorders.